US FDA Approves Abbott’s Sensor-Enabled TactiCath AF Catheter
Executive Summary
The TactiCath - Sensor Enabled contact-force ablation catheter is indicated for cardiac electrophysiological mapping and the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. It adds to Abbott EnSite Precision cardiac mapping system.
Register for our free email digests: